AYALA PHARMACEUTICALS
Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The com... pany has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).
AYALA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.ayalapharma.com
Total Employee:
11+
Status:
Active
Contact:
+972-8-373-1541
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content HSTS Amazon Virginia Region COVID-19 Amazon Route 53 Amazon SSL Akamai Hosted Beaver Builder
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Principia Pharmaceutical Corporation
Principia Pharmaceutical Corporation has created a revolutionary new way to design and develop oral small molecule therapies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-07-27 | BioSight | BioSight acquired by Ayala Pharmaceuticals | N/A |
| 2023-01-19 | Advaxis | Advaxis acquired by Ayala Pharmaceuticals | N/A |
Investors List
Sio Capital Management
Sio Capital Management investment in Post-IPO Equity - Ayala Pharmaceuticals
Redmile Group
Redmile Group investment in Post-IPO Equity - Ayala Pharmaceuticals
Harel Insurance and Financial
Harel Insurance and Financial investment in Series B - Ayala Pharmaceuticals
aMoon Fund
aMoon Fund investment in Series B - Ayala Pharmaceuticals
Novartis
Novartis investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series B - Ayala Pharmaceuticals
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series A - Ayala Pharmaceuticals
Official Site Inspections
http://www.ayalapharma.com
- Host name: 172.67.139.123
- IP address: 172.67.139.123
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ayala Pharmaceuticals"
Home - Ayala Pharmaceuticals
AL102 and AL101 were acquired in Q1 2024 by Immunome, Inc.See details»
Ayala Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number +972-8-373-1541 Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing …See details»
Ayala Pharmaceuticals Announces Closing of Merger …
Oct 19, 2023 Management and Organization. ... For more information, visit www.ayalapharma.com. Contacts: Ayala Pharmaceuticals: +1-857-444-0553 [email protected]. Story Continues Terms ...See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger …
Jul 27, 2023 Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayala’s portfolio with data anticipated in the first half of 2024 …See details»
Ayala Pharmaceuticals - Israeli Startup | Startup Nation Finder
Jul 27, 2023 https://ayalapharma.com. Locations. Israel. Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel Offices Abroad. 1007 North Orange Street, Wilmington, DE, USA Photos & …See details»
Ayala Pharmaceuticals (ADXS) Company Profile & Description
6 days ago Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors …See details»
Ayala Pharmaceuticals - LifeScienceHistory.com
Ayalapharma.com. 9 Deer Park Drive, Suite K-1. Monmouth Junction, NJ 08852. Company Info Phone (857) 444-0553 Year Established 2017 Ticker ADXS Exchange OTCQX. Contacts Ken …See details»
Annual Reports - Ayala Pharmaceuticals
1007 North Orange Street, 4th Floor, Wilmington, DE 19801. +1-857-444-0553 . 9 Deer Park Drive, Suite K-1 Monmouth Junction, NJ 08852See details»
Ayala Pharmaceuticals - Craft
Jan 27, 2023 Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. The company offers AL101 and AL102 …See details»
Ayala Pharmaceuticals Announces Closing of Merger with
Oct 19, 2023 Management and Organization. As previously announced, the combined company will be led by Ayala’s existing senior management team, with Ken Berlin serving as President …See details»
Ayala Pharmaceuticals - Company Profile & Staff Directory
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and …See details»
Ayala Pharmaceuticals, Inc.
Feb 5, 2025 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
Merger brings U.S. management and presence, cash to develop compelling late-stage asset. Lead candidate AL102 being evaluated in ongoing Phase 2/3 RINGSIDE study, a potential …See details»
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to …
Mar 26, 2024 For more information, visit www.ayalapharma.com. Cautionary Statement Regarding Forward-Looking Statements The statement contained in this release that Ayala …See details»
Ayala Pharmaceuticals - Overview, News & Similar companies
Ayala Pharmaceuticals contact info: Phone number: +972 83731541 Website: www.ayalapharma.com What does Ayala Pharmaceuticals do? Ayala Pharmaceuticals, Inc., a …See details»
Ayala Pharmaceuticals Company Profile | Management and
Www.ayalapharma.com Ayala Pharmaceuticals Profile and History Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule …See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive
Jul 27, 2023 Management and Organization. ... For more information, visit www.ayalapharma.com. About AL102. AL102 is an investigational small molecule gamma …See details»
Ayala Pharmaceuticals Company Overview, Contact Details
Feb 19, 2021 This presents a potential sales opportunity for companies looking to be acquired by a growing oncology-focused organization. ... Jul 05, 2023 | ayalapharma.gcs-web.com. …See details»
Philippines’ Ayala Corp. Aims To Quadruple AC Health’s ... - Forbes
1 hour ago Ayala Corp. president and CEO Bong Consing said the conglomerate has poured about 15 billion pesos into AC Health since it started in 2015, and has expanded rapidly in the …See details»
News Releases - Ayala Pharmaceuticals
Feb 6, 2024 MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced …See details»